CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Subsidiary
- Established
- 1992-11-04
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.cuh.org.uk
Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides
Phase 2
Completed
- Conditions
- ANCA Associated Systemic VasculitisWegener's GranulomatosisMicroscopic Polyangiitis
- First Posted Date
- 2007-02-01
- Last Posted Date
- 2007-02-01
- Target Recruit Count
- 160
- Registration Number
- NCT00430105
Epidural Clonidine for Postoperative Hyperalgesia
Phase 3
Withdrawn
- Conditions
- Postoperative Hyperalgesia
- Locations
- π¬π§
Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom
Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis
- First Posted Date
- 2006-12-21
- Last Posted Date
- 2013-12-06
- Target Recruit Count
- 140
- Registration Number
- NCT00414128
- Locations
- π¬π§
Addenbrookes Hospital, Cambridge, Cambridgeshire, United Kingdom
Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis
Phase 2
Completed
- Conditions
- Systemic Lupus ErythematosusANCA Associated Vasculitis
- First Posted Date
- 2006-02-17
- Last Posted Date
- 2006-02-17
- Target Recruit Count
- 20
- Registration Number
- NCT00293072
- Locations
- π¬π§
Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom
Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer
Phase 3
- Conditions
- Breast Cancer
- First Posted Date
- 2003-10-07
- Last Posted Date
- 2013-08-07
- Target Recruit Count
- 800
- Registration Number
- NCT00070278
- Locations
- π¬π§
Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust, Cambridge, England, United Kingdom
Β© Copyright 2025. All Rights Reserved by MedPath